氨酸丰富的重复激酶2的Rab29依赖的不对称激活
Hanwen Zhu1, Francesca Tonelli2,3, Martin Turk4
1Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
概括
氨酸丰富的重复激酶2 (LRRK2) 的功能增益突变导致帕金森病. 新结构揭示了Rab29如何激活LRRK2,为开发LRRK2抑制剂治疗帕金森病提供了洞察力.
科学领域:
- 神经科学
- 结构生物学
- 遗传学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 的功能获取突变是晚发帕金森病的最常见遗传原因.
- LRRK2的激活是空间调节的,并涉及Rab29,一个Rab GTPase对膜器官的招募.
研究的目的:
- 通过Rab29阐明LRRK2激活的结构机制.
- 提供对帕金森病LRRK2抑制剂设计的见解.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 来确定Rab29-LRRK2复合物的结构.
- 在LRRK2招募和激活过程中捕获的三个不同的寡合状态的分析.
主要成果:
- Rab29诱导了LRRK2的新型四基组合,其中包括两个活跃的中心原体和两个不活跃的外围原体.
- 四聚体中的活性LRRK2原体类似于DNL201等I型激酶抑制剂的向形状.
结论:
- 该研究揭示了Rab29对LRRK2空间调节的结构基础.
- 这些发现为合理设计用于帕金森病治疗的LRRK2抑制剂提供了关键的见解.
更多相关视频
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
1.1K
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.1K
相关概念视频
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Receptor Tyrosine Kinases
13.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
